Elaine Grant, LADAC Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 152 S Hamletsburg Rd, Brookport, IL 62910 Phone: 615-967-8978 |
News Archive
Pluristem Therapeutics Inc. today announced that it has entered into definitive agreements with selected investors to sell restricted common stock and warrants for aggregate gross proceeds of approximately $2.7 million. The offering includes 2,420,293 shares of common stock, warrants to purchase 726,088 shares of common stock at an exercise price of $1.25 per share and warrants to purchase 726,088 shares of common stock at an exercise price of $1.40 per share.
Watson Pharmaceuticals, Inc. today announced that it has completed the acquisition of Eden Biopharm Group Limited for approximately $15 million. Eden is a biopharmaceutical development and contract manufacturing company located in Liverpool, UK. As a result of the acquisition of the Arrow Group in December 2009, Watson had previously acquired approximately 36 percent of Eden.
Johns Hopkins scientists report having used a commercially available drug to successfully "rescue" animal brain cells that they had intentionally damaged by manipulating a newly discovered gene that links susceptibility genes for schizophrenia and autism.
The Leeds Teaching Hospitals NHS Trust is continually striving to provide high quality, patient centred care to each and every patient. Smart Cells International, in association with the trust, will be introducing the option for patients to privately store stem cells from the umbilical cord across St James's University Hospital, Leeds General Infirmary and Wharfedale Hospital.
"If we don't leverage the power of innovation to transform how health services are provided and utilized, efforts to stop new HIV infections and AIDS-related deaths can reach a stalemate," UNAIDS Executive Director Michel Sidibe writes in this opinion piece in the Huffington Post's "Healthy Living" blog.
› Verified 5 days ago